| Filed On | Filing |
|---|---|
| 13 Jan 2026 |
Form 3: Krigsvold Terah Renee, Chief Financial Officer
Holds 1 shares of Common Stock |
| 21 Jun 2021 |
Form 3: Goren Andrea, Chief Financial Officer
Holds 12,500 shares of Common Stock |
| 11 May 2021 |
Form 3: Awm Investment Company, Inc., 10% owner
Holds 1,052,820 shares of Common Stock |
| 30 Apr 2021 |
Form 3: Messina Rebecca, Director
No securities owned |
| 17 Nov 2020 |
Form 3: Segal Jeffrey, Director
No securities owned |
| 05 Oct 2020 |
Form 3: Ryan Barbara, Director
No securities owned |
| 29 Sep 2020 |
Form 3: Szot Matthew K, Director
No securities owned |
| 23 Dec 2019 |
Form 3: Davis Trent D, Director
No securities owned |
| 30 Sep 2019 |
Form 3: Hoopes Debra Robbins, Acting CFO and PFO
No securities owned |
| 26 Sep 2019 |
Form 3: Doody Kevin, Director
Holds 5,073,197 shares of Common Stock |
| 26 Sep 2019 |
Form 3: Campbell Michael Jos., Director
Holds 607,800 shares of Common Stock |
| 26 Sep 2019 |
Form 3: Shum Steve, Director
Holds 600,000 shares of Common Stock |
| 26 Sep 2019 |
Form 3: Bowdring Robert Joseph Jr, Director
Holds 11,715,942 shares of Common Stock |
| 26 Sep 2019 |
Form 3: Karloff Kathleen t, Director
Holds 14,200,183 shares of Common Stock |
| 23 Jan 2018 |
Form 3: Campbell Michael Jos., Director
Holds 7,800 shares of Restricted Common Stock |
| 18 Oct 2017 |
Form 3: Shum Steve, Director
No securities owned |
| 03 Jul 2017 |
Form 3: Karloff Kathleen t, Director
Holds 5,622,159 shares of INVO Bioscience Common Stock Restricted |
| 03 Jul 2017 |
Form 3: Bowdring Robert Joseph Jr, Chief Financial Officer
No securities owned |
Loading...